Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eimeria maxima is a unicellular eukaryotic parasite belonging to the phylum Apicomplexa. It is one of several Eimeria species that cause coccidiosis, an enteric disease affecting chickens and other poultry. This organism specifically targets the middle part of the small intestine (jejunum and ileum), often causing lesions limited to this region. Infection leads to dilatation/thickening of intestinal wall, petechial hemorrhage, reddish/orange/pink viscous mucous exudate, and fluid accumulation primarily in jejunum/ileum regions. Clinical signs include reduced growth performance, increased morbidity/mortality due to impaired nutrient absorption and secondary infections such as necrotic enteritis.
Diclazuril acts later during infection but effectively reduces lesion scores caused by E. maxima
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eimeria maxima.